We were interested in proteins that are known to be expressed in subsets of malignant glial tumours: while some proteins have been studied for this purpose in the past (EGFR) [24], others have been mostly studied in unrelated pathological processes (INSM1, SOX11, CD34) or have been studied only rarely in the context of diagnostic pathology (MEOX2). The gene discussed is MEOX2; the disease is glioma.